Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • onology

    - PMLiVE

    Pfizer’s Lorviqua recommended by NICE for lung cancer

    Lung cancer is the leading cause of cancer-related deaths worldwide

    - PMLiVE

    David Weinreich appointed as Merck’s Global Head of R&D and CMO, Healthcare

    Weinreich will be based in Billerica, Massachusetts at the company’s Research and Development site

    - PMLiVE

    Boehringer’s Hernexeos granted FDA accelerated approval for lung cancer patients

    Approximately 226,650 lung cancer cases are expected to be diagnosed in the US this year

    EU flag

    CHMP recommends BeOne Medicines’ Tevimbra for new lung cancer indication

    Non-small cell lung cancer accounts for up to 90% of all lung cancer cases

    - PMLiVE

    AstraZeneca shares late-stage results for Tagrisso combination in lung cancer

    An estimated 2.4 million people globally are diagnosed with lung cancer each year

    - PMLiVE

    FDA approves Dizal’s oral therapy Zegfrovy to treat advanced lung cancer

    Around 226,650 new cases of lung cancer are expected to be diagnosed in the US this year

    - PMLiVE

    MHRA approves Accord Healthcare’s Hetronifly to treat aggressive form of lung cancer

    Small cell lung cancer accounts for up to 15% of all lung cancer diagnoses

    - PMLiVE

    AstraZeneca/Daiichi Sankyo’s Datroway granted FDA accelerated approval for lung cancer

    Approximately 226,650 new cases of lung cancer will be diagnosed in the US this year

    - PMLiVE

    Roche/Jazz share positive phase 3 results for lung cancer combination therapy

    Approximately 30,000 new cases of small cell lung cancer are reported in the US every year

    - PMLiVE

    Bristol Myers Squibb’s perioperative Opdivo regimen granted EC approval in NSCLC

    Up to 55% of patients with non-metastatic NSCLC develop recurrence despite curative resection

    - PMLiVE

    Pfizer gains rights to 3SBio’s investigational bispecific antibody in deal worth over $6bn

    The candidate is in clinical development for colorectal cancer, lung cancer and gynaecological tumours

    - PMLiVE

    AbbVie’s Emrelis granted FDA accelerated approval to treat advanced lung cancer

    An estimated 226,650 people will be diagnosed with lung cancer in the US this year

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links